# Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.

> **NCT06025227** · — · AVAILABLE · sponsor: **Pfizer**

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** Etrasimod

## Key facts

- **NCT ID:** NCT06025227
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06025227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06025227, "Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06025227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*